CINtec PLUS Webinar Series
bannerimage

Optimizing triage of HPV positive patients with p16/Ki67 dual stain biomarkers: Singapore experience

Thursday, 16th May 2024
13:00 - 14:00 (GMT +8)
View other Time Zones

The goal of cervical cancer screening is to detect precancerous lesions, which if left untreated, can develop into cervical cancer. While Pap cytology has had a positive impact on HPV and cervical cancer screening over the past 50 years, it is resource-intensive and subject to misinterpretation and missed disease.

By harnessing p16-Ki67 dual-biomarker immunocytochemistry, FDA-approved CINtec® PLUS Cytology serves as an objective indicator of transforming HPV infections in patients with abnormal Pap cytology and/or HPV-positive screening results.

In this webinar, our experts unveil how p16-Ki67 dual biomarker testing optimizes triage processes and allows lab professionals to help clinicians be more certain in selecting women who may benefit most from colposcopy and in follow up recommendations.

Join us in this session, as they share their experience with CINtec® PLUS biomarker testing, as a triage tool in managing patients with abnormal Pap and/or HPV-positive results.

Who should attend:

  • Gynecologists / Gyne-oncologists, Pathologists, Laboratory staff / lab scientists, Cytotechnologists, General practitioners, Health practitioners involved in women’s health, Residents/trainees or any professionals interested in understanding molecular diagnostics relevant to cervical cancer screening.

Key reasons to attend:

  • Learn about the latest advancements in cervical cancer screening with FDA-approved CINtec® PLUS Cytology, harnessing dual-biomarker p16-Ki67 immunocytochemistry, to enhance accuracy in detecting transforming HPV infections.
  • Discover how p16/Ki67 dual stain biomarker testing streamlines triage processes for HPV positive or abnormal Pap cytology results, enabling confident follow-up recommendations and improved patient outcomes.
  • Gain insights into how p16/Ki67 dual stain biomarker testing enables clinicians optimize cervical disease management workflow and resource allocation.

Faculty

Speaker

speaker1

Prof. Tay Sun Kuie

Senior Consultant Obstetrician and Gynecologist
Singapore General Hospital

Read More

Speaker

speaker2

Dr. Sangeeta Mantoo

Senior Consultant, Anatomical Pathology
Singapore General Hospital

Read More

Moderator

speaker4

Dr. Richie Lazaro

Regional Pathologist APAC
Roche Diagnostics Asia Pacific Pte Ltd

Read More

Agenda

TIME

TOPIC

Speakers


13:00 – 13:05
Opening
Dr. Richie Lazaro

13:05 - 13:25
The value and role of dual-stain cytology using p16/Ki67 biomarkers, in triage processes and risk-based management of cervical cancer screening
Prof. Tay Sun Kuie

13:25 - 13:45
Implementation of dual stain cytology in the lab, and insights and challenges in routine practice
Dr. Sangeeta Mantoo

13:45 - 14:00
Q&A
All


Live Webinar Date & Time

image5

Date:

16th May 2024 at 13:00-14:00 (GMT+8)

image6

Time:

13:00 - 14:00

(GMT+08:00)

10:00 - 11:00

(Karachi)

10:30 - 11:30

(Delhi)

12:00 - 13:00

(Bangkok / Ho Chi Minh / Jakarta)

13:00 - 14:00

(Hong Kong / Kuala Lumpur / Singapore)

14:00 - 15:00

(Seoul / Tokyo)

15:00 - 16:00

(Melbourne)

17:00 - 18:00

(New Zealand)